CIBINQO
Identification of Cibinqo
| No description |
Google image searchProduct monograph
Active ingredient
abrocitinib, 50 MG
DIN: 02528363
Dosage form(s): TABLET
Route(s) of administration: ORAL
Schedule: Prescription
Company: PFIZER CANADA ULC
Date: 29-SEP-2022
ATC:
- D11 — OTHER DERMATOLOGICAL PREPARATIONS (ATC, ATC/DDD, )
- D11A — OTHER DERMATOLOGICAL PREPARATIONS (ATC, ATC/DDD)
- D11AH — Agents for atopic dermatitis, excluding corticosteroides (ATC, ATC/DDD)
- D11AH08 — ABROCITINIB (ATC/DDD)
Reference brand drug: Cibinqo
